Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Cormorant Asset Management’

Three Biotech Investment Ideas from Cormorant Asset Management

The biotech industry is regaining ground it lost in 2016 at full speed. The sector was very hot until around mid-2015, with the iShares Nasdaq Biotechnology......(read more)

July 19 - Hedge Funds, News - Comments

13G Filing: Cormorant Asset Management and Ignyta Inc. (RXDX)

Ignyta Inc. (NASDAQ:RXDX): Bihua Chen’s Cormorant Asset Management filed an amended 13D. You can check out Cormorant Asset Management’s latest......(read more)

September 12 - Hedge Funds - Comments

13G Filing: Cormorant Asset Management and Trillium Therapeutics Inc. (TRIL)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)

June 6 - Hedge Funds - Comments

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) has a new shareholder in the form of Bihua Chen‘s Cormorant Asset Management. As per a new 13G filing......(read more)

November 2 - Hedge Funds, News - Comments

30 Funniest Science Jokes, Puns, and Humor Quotes Ever

Myokardia Inc (MYOK): Cormorant Asset Management Raises Its Stake

A recent 13G filing with the Securities and Exchange Commission revealed that Bihua Chen‘s Cormorant Asset Management has boosted its stake in ......(read more)

October 14 - Hedge Funds, News - Comments

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Cormorant Asset Management Doesn’t Think Corbus Pharmaceuticals Holdings Inc. (CRBP) Is Done Soaring Just Yet

In a new 13G filing with the SEC, Bihua Chen‘s Cormorant Asset Management reported owning 2.35 million shares of Corbus Pharmaceuticals Holdings......(read more)

September 30 - Hedge Funds, News - Comments

Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake

According to a new 13G filing with the Securities and Exchange Commission, Bihua Chen‘s Cormorant Asset Management owns 900,000 shares of Gemphire......(read more)

August 16 - Hedge Funds, News - Comments

cell, stem, research, cold, liquid, nitrogen, medical, test, experiment, clothing, protective, artificial, white, temperature, laboratory, freeze, cryopreservation, samples,

Clearside Biomedical Inc (CLSD): Cormorant Reveals 10.1% Stake

Bihua Chen‘s Cormorant Asset Management has revealed a position in Clearside Biomedical Inc (NASDAQ:CLSD), through a 13G filing issued with the......(read more)

June 14 - Hedge Funds, News - Comments

Quotient Ltd (QTNT): Bihua Chen’s New Fund, Cormorant Asset Management, Triples Stake

Bihua Chen’s Cormorant Asset Management disclosed, last Thursday, that it had tripled its exposure to Quotient Ltd (NASDAQ:QTNT), from 500,000 shares......(read more)

December 5 - Hedge Funds, News - Comments